Levrx
Levrx is a Troy, NY-based healthcare IT company whose B2B pharmacy navigation platform connects payers, providers, pharmacies, and patients, serving self-insured employers, health plans, PBMs, and benefit consultants with AI-driven real-time pricing, savings recommendations, and specialty medication management across 7 million covered lives.
- Company typePrivate
- Founded2016
- HeadquartersTroy, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Levrx does
Levrx Technology, Inc. is a Troy, New York-based healthcare IT company that operates a B2B pharmacy navigation and engagement platform connecting payers, providers, pharmacies, and patients. Founded in 2016 by serial entrepreneurs Vikash Agrawal (Executive Chairman) and Vikram Agrawal (President & CEO) following their exit from Etransmedia, Levrx targets plan sponsors — self-insured employers, health plans, PBMs, and benefits consultants/brokers — with a white-labeled web and mobile platform that consolidates 25+ PBMs, pharmacy programs, benefits, and fulfillment pathways into a single member experience. The platform surfaces real-time drug pricing, clinically appropriate alternatives, and specialty medication visibility while directing members to lower-cost options before they fill a prescription. Compliance posture includes SOC 2 Type 2, HIPAA, and HITECH certifications.
The core technology stack is built around Roxanne AI™, Levrx's proprietary machine learning engine that analyzes formulary data, benefit design, and member medication history to recommend optimal savings outcomes, complemented by pharmacist-to-prescriber clinical engagement workflows. Product modules include the Levrx Member Platform (web/mobile), the Levrx Practice Platform (provider-facing), a Specialty Marketplace Lever (Feb 2026), and a Pre-Login Experience (Jan 2026). The platform was serving 7 million covered lives as of January 2026, adding roughly 1 million new lives per quarter throughout 2025, with the company stating plans to more than double covered lives in 2026. Strategic integrations include partnerships with Waltz Health (transparent specialty pharmacy marketplace, April 2026) and a U.S. technology provider + Canadian pharmacy network (May 2026, international sourcing).
Revenue is generated through subscription/enterprise licensing on a per-covered-life basis with quote-based annual contracts, supplemented by outcomes-driven value tied to realized pharmacy savings. Go-to-market is sales-led with an enterprise field sales team (SVP Sales Todd Edwards), a channel-partnership function (VP Channel Partnerships), and account management led by VP Marketing & Account Management Lauren Sgambati. Operating geographies are currently U.S.-only, with the legal entity governed by New York law. The company is privately held and bootstrapped to date, with no disclosed funding rounds, parent entity, or institutional investment in the source data.
Levrx firmographics
Firmographics- Name
- Levrx
- Legal name
- Levrx Technology, Inc.
- Website
- https://levrx.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Levrx is a Troy, NY-based healthcare IT company whose B2B pharmacy navigation platform connects payers, providers, pharmacies, and patients, serving self-insured employers, health plans, PBMs, and benefit consultants with AI-driven real-time pricing, savings recommendations, and specialty medication management across 7 million covered lives.
- Ownership category
- akta.pro rank
Levrx industry classification
Industry- Product category
- Pharmacy Navigation Software
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- akta.pro primary industry
- PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)
- akta.pro secondary industries
- Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where Levrx is headquartered
LocationHeadquarters
- HQ city
- Troy
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Levrx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- B2B Platform / Software Subscription: Levrx operates as a B2B software platform sold to plan sponsors (employers, health plans, PBMs, consultants/brokers). The platform is white-labeled per client with configurable program visibility, messaging, branding, and eligibility logic. Revenue is generated through software licensing/subscription fees from plan sponsors who deploy the platform to their member populations. The company serves 7 million+ lives as of January 2026, adding ~1 million new lives per quarter.
- Member Engagement & Savings Capture: Revenue is tied to realized pharmacy savings and measurable outcomes delivered to plan sponsors. The platform generates value by identifying and capturing savings across populations — including specialty medications, brand-to-generic switches, pharmacy switches, and fulfillment alternatives — with reporting on savings identified vs. captured, engagement metrics, and channel shifts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | B2B enterprise licensing — pricing based on covered lives and program scope |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Levrx product offering
Product offeringCore offering
Levrx sells a B2B pharmacy navigation and engagement platform that connects payers, providers, pharmacies, and patients into a single white-labeled digital experience. The platform unifies 25+ PBMs, pharmacy programs, benefits, vendors, and fulfillment pathways; its proprietary Roxanne AI engine analyzes formularies, benefits, and pharmacy networks to deliver real-time pricing, clinically appropriate lower-cost alternatives, one-click prescription transfers, and proactive savings alerts to plan-sponsor members. Pricing is subscription-based, quoted per covered life with annual billing.
Product overview
Levrx is a pharmacy navigation and engagement platform that unifies pharmacy benefits, clinical programs, and vendor integrations into a single digital experience. The core platform consists of the Levrx Member Platform (web and mobile app) powered by Roxanne AI™ for personalized guidance. Key modules include the Specialty Marketplace Lever for specialty medication visibility, Pre-Login Experience for early member engagement, and the Levrx Practice Platform for providers. The platform connects 25+ PBMs and integrates with partners like Waltz Health, Mark Cuban Cost Plus Drug Company, and Amazon Pharmacy to deliver real-time pricing, savings opportunities, and fulfillment alternatives.
Differentiator
Problem solved
Functional benefit
Brands
- Roxanne AI™: AI-driven pharmacy navigation and savings optimization engine that analyzes pharmacy and benefit information to identify real savings opportunities and deliver personalized guidance to members.
Products and services
- Levrx Member Platform White-labeled pharmacy navigation and engagement hub delivered through web and mobile that connects plan-sponsor members with their pharmacy benefits, enabling real-time pricing comparison, medication cost transparency, savings opportunity identification, prescription transfers, and Specialty Marketplace Lever integration in one digital experience.
- Roxanne AI™ Proprietary machine learning engine that analyzes plan-specific formularies, benefit designs, and pharmacy networks to identify the best available cost-saving option and clinically appropriate alternatives for each member in real time, powering Levrx's Savings Center, Specialty Marketplace Lever, and personalized pharmacy guidance.
- Levrx Practice Platform Provider-facing offering that unites payers, providers, pharmacies, and patients for healthcare practices; delivers real-time pricing, formulary insights, and lower-cost prescription alternatives to clinicians to reduce administrative burden, enhance patient experience, and improve outcomes.
Quantifiable outcome
- $917 average savings per specialty prescription (Waltz Health case study basis for Levrx-Waltz partnership)
- +7 more outcomes
Companies that use Levrx
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles4 records
Levrx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
Levrx partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered strategic expansion, core / flagship and foundational / core.
- U.S.-based technology provider and Canadian network of high-tech pharmaciesstrategic expansionLevrx announced a strategic partnership with a U.S.-based technology provider and a Canadian network of high-tech pharmacies to expand pharmacy savings capabilities. The partnership will deliver international sourcing opportunities for eligible medications, specialty drug savings pathways, and greater pharmacy flexibility through Levrx's platform. The partnership identifies eligible members and manages the full authorization and physician coordination process, targeting employers seeking sustainable pharmacy cost strategies.
- Waltz Healthcore / flagshipLevrx and Waltz Health announced a partnership on April 1, 2026, integrating Waltz Health's AI-driven transparent pharmacy marketplace into the Levrx pharmacy navigation platform. The integration brings Waltz Health's specialty medication management and discount-card programs into the Levrx member experience, allowing members to compare transparent pricing and access cost-containment solutions within a single digital experience. Waltz Health's platform has demonstrated average savings of $917 per specialty prescription, 14% cost reduction, and 90% biosimilar conversion rates. Waltz Health is an EVERSANA company.
- Waltz Healthcore / flagshipComplementing the PR Newswire announcement, a second news source (briefglance) confirms the Levrx-Waltz Health partnership integrating Waltz Health's AI-driven transparent pharmacy marketplace into Levrx's platform to address high-cost specialty medications. The collaboration specifically targets high-cost specialty medications with Waltz Health demonstrating $917 per specialty prescription savings, 14% cost reduction, and 90% biosimilar conversion rate. The partnership enters a market where three large PBMs control roughly 80% of prescription claims.
- Hudson Headwaters Health Networkfoundational / coreHudson Headwaters Health Network, a nonprofit system of 21 community health centers serving the Adirondack North Country and Glens Falls region with over 850 staff members, partnered with Levrx to provide employees and family members a digital prescription savings tool. The LevRx mobile app displays personalized drug pricing and alternatives in real-time, proactively alerts employees of cost-saving opportunities, and enables one-click savings. Hudson Headwaters was celebrating its 40th anniversary in 2021.
- CDPHPfoundational / coreCDPHP and Levrx partnered to provide patients and doctors with a tool to search for the most cost-effective drugs and where to purchase them in real-time. Levrx developed the CDPHP Pharmacy Connect app for members and the Levrx Provider Application for physicians. CDPHP is a not-for-profit health plan established in 1984, serving members in 26 counties throughout New York — the first major health plan in the Capital Region to bring this technology to its members.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Levrx competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Levrx social profiles
Digital presenceLevrx compliance and trust
Trust signalCompliance3 records
Levrx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Levrx leadership team
Management profileNumber of profiles
Profiles7 records
Levrx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Levrx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Levrx
What does Levrx do?
Levrx sells a B2B pharmacy navigation and engagement platform that connects payers, providers, pharmacies, and patients into a single white-labeled digital experience. The platform unifies 25+ PBMs, pharmacy programs, benefits, vendors, and fulfillment pathways; its proprietary Roxanne AI engine analyzes formularies, benefits, and pharmacy networks to deliver real-time pricing, clinically appropriate lower-cost alternatives, one-click prescription transfers, and proactive savings alerts to plan-sponsor members. Pricing is subscription-based, quoted per covered life with annual billing.
Is Levrx a public or private company?
Levrx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Levrx founded?
Levrx was founded in 2016. It employs 11 to 50 people.
Where is Levrx based?
Levrx is headquartered in Troy, United States, in the North America region.
How does Levrx make money?
Two revenue lines are on record. B2B Platform / Software Subscription is the primary driver. The others are member Engagement & Savings Capture.
Does Levrx have an API?
No public API is recorded for Levrx.
What industry is Levrx in?
Levrx's product category is Pharmacy Navigation Software. Its primary akta.pro industry code is HLAEAKAL, PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools), with a secondary code of HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools. Its NAICS code is 524292.